Toggle navigation
Home
About
Mission
Management Team
Scientific Advisory Board
Board of Directors
Research & Development
Technology
Pipeline
Galactosemia
Diabetic Complications
Cardiovascular Disease
Newsroom
Press
Presentations & Publications
Contact
Press
APPLIED THERAPEUTICS TO PRESENT NEW DATA ON NOVEL INVESTIGATIONAL TREATMENT FOR GALACTOSEMIA AT 2018 NORD SUMMIT (October 15, 2018)
APPLIED THERAPEUTICS ANNOUNCES APPOINTMENT OF RICCARDO PERFETTI, MD, PHD, AS CHIEF MEDICAL OFFICER (September 4, 2018)
APPLIED THERAPEUTICS TO PRESENT NEW DATA ON PREVENTION AND TREATMENT OF GALACTOSEMIA COMPLICATIONS AT THE GALACTOSEMIA FOUNDATION CONFERENCE (July 11, 2018)
APPLIED THERAPEUTICS ANNOUNCES SUPPORT FOR RARE DISEASE DAY 2018 - INITIATES GALACTOSEMIA RESEARCH COLLABORATION WITH EMORY UNIVERSITY SCHOOL OF MEDICINE (Feb 20, 2018)
APPLIED THERAPEUTICS INITIATES PHASE 1 TRIAL FOR AT-001 IN DIABETIC COMPLICATIONS (Feb 12, 2018)
APPLIED THERAPEUTICS CLOSES SERIES A FINANCING (Feb 14, 2017)